Skip to main content
editorial
. 2020 Jun 20;125(3):238–242. doi: 10.1016/j.bja.2020.06.013

Fig 1.

Fig 1

SARS-CoV-2 spike protein binding with angiotensin-converting enzyme 2 (ACE2) receptor enables viral envelope fusion with the host cell membrane and subsequent entry of the viral nucleocapsid into the cell.